LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
LEPU ScienTech Medical Technology has announced a board reshuffle, with Mr. Zheng stepping down as non-executive director and Mr. Zhu taking his place, effective December 9, 2024. Mr. Zhu, with extensive experience in the pharmaceutical sales sector, will also join the company’s Audit and Nomination Committees. These strategic changes are poised to bolster the company’s leadership and governance.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.